Mechanisms of exertional dyspnea in patients with cancer
- 1 January 2008
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 104 (1) , 57-66
- https://doi.org/10.1152/japplphysiol.00653.2007
Abstract
Exertional dyspnea is an important symptom in cancer patients, and, in many cases, its cause remains unexplained after careful clinical assessment. To determine mechanisms of exertional dyspnea in a variety of cancer types, we evaluated cancer outpatients with clinically important unexplained dyspnea (CD) at rest and during exercise and compared the results with age-, sex-, and cancer stage-matched control cancer (CC) patients and age- and sex-matched healthy control participants (HC). Participants ( n = 20/group) were screened to exclude clinical cardiopulmonary disease and then completed dyspnea questionnaires, anthropometric measurements, muscle strength testing, pulmonary function testing, and incremental cardiopulmonary treadmill exercise testing. Dyspnea intensity was greater in the CD group at peak exercise and for a given ventilation and oxygen uptake ( P < 0.05). Peak oxygen uptake was reduced in CD compared with HC ( P < 0.05), and breathing pattern was more rapid and shallow in CD than in the other groups ( P < 0.05). Reduced tidal volume expansion during exercise correlated with reduced inspiratory capacity, which, in turn, correlated with reduced inspiratory muscle strength. Patients with cancer had a relatively reduced diffusing capacity of the lung for carbon monoxide, reduced skeletal muscle strength, and lower ventilatory thresholds during exercise compared with HC ( P < 0.05). There were no significant between-group differences in measurements of airway function, pulmonary gas exchange, or cardiovascular function during exercise. In the absence of evidence of airway obstruction or restrictive interstitial lung disease, the shallow breathing pattern suggests ventilatory muscle weakness as one possible explanation for increased dyspnea intensity at a given ventilation in CD patients.Keywords
This publication has 49 references indexed in Scilit:
- Interstitial lung disease associated with drug therapyBritish Journal of Cancer, 2004
- ATS/ERS Statement on Respiratory Muscle TestingAmerican Journal of Respiratory and Critical Care Medicine, 2002
- The Frequency and Correlates of Dyspnea in Patients with Advanced CancerJournal of Pain and Symptom Management, 2000
- Measurement of lung volumes by plethysmographyEuropean Respiratory Journal, 1997
- American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update.American Journal of Respiratory and Critical Care Medicine, 1995
- Standardization of Spirometry, 1994 Update. American Thoracic Society.American Journal of Respiratory and Critical Care Medicine, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphomaCancer, 1991
- Maximal respiratory pressures: normal values and relationship to age and sex.Published by Elsevier ,1969
- The Relationship Between Airway Resistance, Airway Conductance and Lung Volume in Subjects of Different Age and Body Size12Journal of Clinical Investigation, 1958